References
- Chen T, He J, Huang Y, Zhao W. (2011a). The generation of mitochondrial DNA large-scale deletions in human cells. J Hum Genet 56:689–94
- Chen T, He J, Shen L, Fang H, Nie H, Jin T, Wei X, et al. (2011b). The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet 12:8
- Damas J, Samuels DC, Carneiro J, Amorim A, Pereira F. (2014). Mitochondrial DNA rearrangements in health and disease – A comprehensive study. Hum Mutat 35:1–14
- Dani MA, Dani SU, Lima SP, Martinez A, Rossi BM, Soares F, Zago MA, Simpson AJ. (2004). Less DeltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res 3:395–409
- Dimberg J, Hong TT, Nguyen LT, Skarstedt M, Lofgren S, Matussek A. (2015). Common 4977 bp deletion and novel alterations in mitochondrial DNA in Vietnamese patients with breast cancer. Springerplus 4:58
- Dimberg J, Hong TT, Skarstedt M, Lofgren S, Zar N, Matussek A. (2014). Novel and differential accumulation of mitochondrial DNA deletions in Swedish and Vietnamese patients with colorectal cancer. Anticancer Res 34:147–52
- Goto Y, Nishino I, Horai S, Nonaka I. (1996). Detection of DNA fragments encompassing the deletion junction of mitochondrial genome. Biochem Biophys Res Commun 222:215–19
- Lai LP, Tsai CC, Su MJ, Lin JL, Chen YS, Tseng YZ, Huang SK. (2003). Atrial fibrillation is associated with accumulation of aging-related common type mitochondrial DNA deletion mutation in human atrial tissue. Chest 123:539–44
- Lee HC, Pang CY, Hsu HS, Wei YH. (1994). Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing. Biochim Biophys Acta 1226:37–43
- Lin PH, Lee SH, Su CP, Wei YH. (2003). Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 35:1310–18
- Meissner C, Bruse P, Mohamed SA, Schulz A, Warnk H, Storm T, Oehmichen M. (2008). The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: A useful biomarker or more? Exp Gerontol 43:645–52
- Nie H, Shu H, Vartak R, Milstein AC, Mo Y, Hu X, Fang H, et al. (2013). Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: A meta-analysis of 38 studies. PLoS One 8:e67953
- Nourazarian AR, Kangari P, Salmaninejad A. (2014). Roles of oxidative stress in the development and progression of breast cancer. Asian Pac J Cancer Prev 15:4745–51
- Singh AK, Pandey P, Tewari M, Pandey HP, Shukla HS. (2014). Human mitochondrial genome flaws and risk of cancer. Mitochondrial DNA 25:329–34
- van Guldener C, Stehouwer CD. (2000). Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 26:281–9
- Wei YH. (1992). Mitochondrial DNA alterations as ageing-associated molecular events. Mutat Res 275:145–55
- Wei YH, Lee CF, Lee HC, Ma YS, Wang CW, Lu CY, Pang CY. (2001). Increases of mitochondrial mass and mitochondrial genome in association with enhanced oxidative stress in human cells harboring 4,977 BP-deleted mitochondrial DNA. Ann N Y Acad Sci 928:97–112